Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12621000585820
Ethics application status
Approved
Date submitted
16/04/2021
Date registered
18/05/2021
Date last updated
29/09/2022
Date data sharing statement initially provided
18/05/2021
Type of registration
Prospectively registered
Titles & IDs
Public title
Assessing the effectiveness of Hospital-Based Manufactured Medical Device Restorabite for treatment of Trismus in adults after head and neck cancer surgery
Query!
Scientific title
Efficacy of Hospital-Based Manufactured Medical Device Restorabite for treatment of Trismus in adults after head and neck cancer surgery
Query!
Secondary ID [1]
303969
0
Nil known
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Trismus
321584
0
Query!
Head and Neck Cancer
321585
0
Query!
Condition category
Condition code
Musculoskeletal
319324
319324
0
0
Query!
Other muscular and skeletal disorders
Query!
Cancer
319325
319325
0
0
Query!
Head and neck
Query!
Oral and Gastrointestinal
319326
319326
0
0
Query!
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
The use of Restorabite will be offered to participants for the treatment of trismus after head and neck cancer surgery in place of other standard of care devices such as Ark-J (stacked wooden tongue depressor) or TheraBite.
Restorabite is a mass produced and non-custom made device, however, participants will be assigned to a specific insert by treating speech pathologist and surgeon depending on the severity of trismus and the recovery from the surgery. Participants will be asked to be involved with following interventions.
• Passive jaw range of motion exercises using Restorabite
• Active jaw range of motion exercises using Restorabite
• 10 x 1hr weekly sessions face to face at speech pathology clinic at hospital or over telehealth with speech pathology with minimum 3 years' experience. Gradual progression through the force hierarchy as clinically indicated.
• Home practice: daily for 20 minutes for duration of study (10 weeks).
• Measurement of Interincisal distance at baseline, at the end of 10 x weekly sessions, 6 months and 12 months follow up appointment
Passive and active jaw range of motion exercises is a continuous exercise performed with Restorabite. It involves inserting the pressed down Restorabite between the front teeth and letting the device stretch the jaw (passive motion exercise) then bite down on the mouth guards (active motion exercise). Then repeat the letting go of the bite (passive motion exercise) and biting down on the device (active motion exercise). During the 1 hour weekly session, speech pathologist will determine how many repetitions should be carried out and recommend the duration of each exercise (ie Hold the passive action for 1 minute then hold the active action for 1 minute. Repeat 10 times). Participants will be asked to carry out a personalised exercise regime as home practice every day.
During the 1 hour weekly session, speech pathologist will determine the passive and active motion exercise regime for coming week. Interincisal distance will be measured at the start of the session then participants will be asked to carry out the prescribed exercise regime. Interincisal distance will be measured at the end of the session to observe a change in interincisal distance.
To monitor adherence to the intervention speech pathologists will closely follow up participants. To increase the adherence to the intervention, speech pathologists will set up a 10 week appointment plan at the beginning of the trial and also offer tele-health appointments.
Query!
Intervention code [1]
320278
0
Treatment: Devices
Query!
Comparator / control treatment
No control group
Query!
Control group
Uncontrolled
Query!
Outcomes
Primary outcome [1]
327195
0
Change in interincisal distance (distance between central incisors. If no dentition, 10mm for each set of teeth will be subtracted) measurement by speech pathologist with a minimum 3 years of experience using the TheraBite Range-of-Motion (ROM) (disposable paper measuring scales, specifically designed to allow patients and providers to measure the opening, movement and function of the mouth and jaw).
Query!
Assessment method [1]
327195
0
Query!
Timepoint [1]
327195
0
At baseline, the end of Intervention (10 week sessions), 6 months follow up and 12 months follow up.
Query!
Secondary outcome [1]
394137
0
Change in patient quality of life measured by below questionnaire.
• Gothenburg Trismus Questionnaire: patient reported outcome measure that measures the impact of trismus on the patient’s daily life.
Query!
Assessment method [1]
394137
0
Query!
Timepoint [1]
394137
0
At baseline, the end of Intervention (10 week sessions), 6 months follow up and 12 months follow up.
Query!
Secondary outcome [2]
395518
0
Change in patient quality of life measured by below questionnaire.
• Eating Assessment Tool – 10: patient reported outcome measure that enquires as to the symptoms of swallowing problems for patients
Query!
Assessment method [2]
395518
0
Query!
Timepoint [2]
395518
0
At baseline, the end of Intervention (10 week sessions), 6 months follow up and 12 months follow up.
Query!
Secondary outcome [3]
395519
0
Change in patient quality of life measured by below questionnaire.
• Speech Handicap Index (SHI): patient reported outcome measure that enquires as to the impact of speech problems on a patient’s daily life
Query!
Assessment method [3]
395519
0
Query!
Timepoint [3]
395519
0
At baseline, the end of Intervention (10 week sessions), 6 months follow up and 12 months follow up.
Query!
Secondary outcome [4]
395520
0
Change in patient quality of life measured by below questionnaire.
• MD Anderson Dysphagia Inventory (MDADI): patient reported outcome measure that enquires as to the impact of swallowing problems on a patient’s daily life
Query!
Assessment method [4]
395520
0
Query!
Timepoint [4]
395520
0
At baseline, the end of Intervention (10 week sessions), 6 months follow up and 12 months follow up.
Query!
Secondary outcome [5]
395521
0
Change in patient quality of life measured by below questionnaire.
• McGill Questionnaire (short form): describes the sensory dimension of pain including an overall intensity measure.
Query!
Assessment method [5]
395521
0
Query!
Timepoint [5]
395521
0
At baseline, the end of Intervention (10 week sessions), 6 months follow up and 12 months follow up.
Query!
Eligibility
Key inclusion criteria
• 18 years and older
• Diagnosis of head and neck cancer (HNC)
• Undergone surgery for their HNC
• Patients with an interincisal distance (IID) of 35mm or less
• Willingness to give informed consent
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Patients where trismus therapy is contraindicated due to medical/surgical parameters, guided by their managing physician.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Single group
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
1/07/2021
Query!
Actual
10/08/2021
Query!
Date of last participant enrolment
Anticipated
23/12/2022
Query!
Actual
Query!
Date of last data collection
Anticipated
23/12/2023
Query!
Actual
Query!
Sample size
Target
150
Query!
Accrual to date
120
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW
Query!
Recruitment hospital [1]
20868
0
The Chris O’Brien Lifehouse - Camperdown
Query!
Recruitment hospital [2]
20869
0
Wollongong Hospital - Wollongong
Query!
Recruitment postcode(s) [1]
35689
0
2050 - Camperdown
Query!
Recruitment postcode(s) [2]
35690
0
2500 - Wollongong
Query!
Funding & Sponsors
Funding source category [1]
308350
0
Hospital
Query!
Name [1]
308350
0
Chris O'Brien Lifehouse
Query!
Address [1]
308350
0
119-143 Missenden Road
Camperdown NSW 2050
Query!
Country [1]
308350
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
Chris O'Brien Lifehouse
Query!
Address
119-143 Missenden Road
Camperdown NSW 2050
Query!
Country
Australia
Query!
Secondary sponsor category [1]
309168
0
Government body
Query!
Name [1]
309168
0
Illawarra Shoalhaven Local Health District
Query!
Address [1]
309168
0
Locked Bag 8808
South Coast Mail Centre NSW 2521
Query!
Country [1]
309168
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
308321
0
St Vincent’s Hospital HREC
Query!
Ethics committee address [1]
308321
0
Research Office St Vincent’s Hospital Translational Research Centre 97-105 Boundary Street Darlinghurst NSW 2010
Query!
Ethics committee country [1]
308321
0
Australia
Query!
Date submitted for ethics approval [1]
308321
0
16/04/2021
Query!
Approval date [1]
308321
0
09/06/2021
Query!
Ethics approval number [1]
308321
0
2021/ETH00758
Query!
Summary
Brief summary
This study aims to assess the efficacy of Restorabite, a trismus treatment device, as an early intervention for trismus and its impact on quality of life for patients with head and neck cancer. Who is it for? You may be eligible for this study if you are aged 18 or older, you have a diagnosis of head and neck cancer, and you are experiencing trouble opening your jaw wider than 35mm. Study details Participants will attend 10 x 1 hour weekly sessions with a speech pathologist, where they will be taken through passive and active jaw range of motion exercises. They will also be instructed to complete 20 minutes of home practice daily over the 10 week study period. Data on changes in jaw opening distance and quality of life will be collected over a 12 month period. It is hoped that this study will demonstrate that the Restorabite device is effective in treating trismus in patients with head and neck cancer, which could lead to an improvement in quality of life for these patients.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
110302
0
Prof Jonathan Clark
Query!
Address
110302
0
Chris O'Brien Lifehouse
119-143 Missenden Road
Camperdown NSW 2050
Query!
Country
110302
0
Australia
Query!
Phone
110302
0
+61 2 8514 0268
Query!
Fax
110302
0
Query!
Email
110302
0
[email protected]
Query!
Contact person for public queries
Name
110303
0
Masako Dunn
Query!
Address
110303
0
Chris O'Brien Lifehouse
119-143 Missenden Road
Camperdown NSW 2050
Query!
Country
110303
0
Australia
Query!
Phone
110303
0
+61 2 8514 0411
Query!
Fax
110303
0
Query!
Email
110303
0
[email protected]
Query!
Contact person for scientific queries
Name
110304
0
Jonathan Clark
Query!
Address
110304
0
Chris O'Brien Lifehouse
119-143 Missenden Road
Camperdown NSW 2050
Query!
Country
110304
0
Australia
Query!
Phone
110304
0
+61 2 8514 0268
Query!
Fax
110304
0
Query!
Email
110304
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Current supporting documents:
Doc. No.
Type
Citation
Link
Email
Other Details
Attachment
11380
Study protocol
381811-(Uploaded-16-04-2021-09-26-46)-Study-related document.docx
11381
Informed consent form
381811-(Uploaded-16-04-2021-09-27-03)-Study-related document.doc
Updated to:
Doc. No.
Type
Citation
Link
Email
Other Details
Attachment
11380
Study protocol
381811-(Uploaded-21-11-2023-15-40-29)-Study-related document.docx
11381
Informed consent form
381811-(Uploaded-21-11-2023-15-40-09)-Study-related document.doc
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF